Cordatus Wealth Management’s Pfizer PFE Stock Holding History

Cordatus Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-51,071	Closed	-$1.87M	–	119
2023 Q2	$1.87M	Buy	+51,071	New	+$1.99M	0.7%	50
2022 Q4	–	Sell	-6,888	Closed	-$301K	–	94
2022 Q3	$301K	Sell	6,888 -248	-3%	-$12.1K	0.32%	52
2022 Q2	$374K	Buy	7,136 +1,078	+18%	+$54.9K	0.17%	121
2022 Q1	$314K	Sell	6,058 -39,424	-87%	-$2.05M	0.11%	137
2021 Q4	$2.69M	Buy	+45,482	New	+$2.25M	0.79%	44

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cordatus Wealth Management's PFE Position: Q3 2023 in Review

Cordatus Wealth Management sold out of Pfizer (PFE) in Q3 2023, closing a stake of 51,071 shares — an estimated $1.87M sold.

Cordatus Wealth Management first reported a position in PFE in Q4 2021 and held it in 5 quarters. The position peaked at $2.69M in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Cordatus Wealth Management reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Cordatus Wealth Management sold 51,071 Pfizer shares in Q3 2023, an estimated $1.87M.
Cordatus Wealth Management first reported a position in Pfizer in Q4 2021 and held it in 5 quarters.
Cordatus Wealth Management's Pfizer position peaked at $2.69M in Q4 2021.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Cordatus Wealth Management's 13F filing for Q3 2023, filed 31 Oct 2023.